価格表

在庫・価格 : 2024年05月22日 17時09分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Rat Nephrin ELISA Kit
データシート※最新のデータシートでない場合があります
1036 EXOエクソセル
EXOCELL Division of Ethos Biosciences, Inc.
1 kit ¥194,000
(未発注)
追加

在庫・価格 : 2024年05月22日 17時09分 現在

Rat Nephrin ELISA Kit

  • 商品コード:1036
  • メーカー:EXO
  • 包装:1kit
  • 価格: ¥194,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Turbeville HR et al. Superimposed Preeclampsia Exacerbates Postpartum Renal Injury Despite Lack of Long-Term Blood Pressure Difference in the Dahl Salt-Sensitive Rat. Hypertension 2019 03;73(3):650-658
Turbeville HR et al
2019/01/01
PubMed
2 Wang X et al. Spontaneous one-kidney rats are more susceptible to develop hypertension by DOCA-NaCl and subsequent kidney injury compared with uninephrectomized rats. Am. J. Physiol. Renal Physiol. 2016 05;310(10):F1054-64
Wang X et al
2016/01/01
PubMed
3 Saleh MA et al. Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Hypertension 2010 Nov;56(5):942-9
Saleh MA et al
2010/01/01
PubMed
4 Brouwers O et al. Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. Diabetologia 2014 Jan;57(1):224-35
Brouwers O et al
2014/01/01
PubMed
5 Jin C et al. Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome. J. Pharmacol. Exp. Ther. 2014 Nov;351(2):467-73
Jin C et al
2014/01/01
PubMed
6 Kojima N et al. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats. J. Pharmacol. Exp. Ther. 2013 Jun;345(3):464-72
Kojima N et al
2013/01/01
PubMed
7 Chen YM et al. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling. Mol. Med. 2015 Apr;21:276-84
Chen YM et al
2015/01/01
PubMed
8 Bernardi S et al. Aldosterone effects on glomerular structure and function. J Renin Angiotensin Aldosterone Syst 2015 Dec;16(4):730-8
Bernardi S et al
2015/01/01
PubMed
9 Jin C et al. Antihypertensive and anti-inflammatory actions of combined azilsartan and chlorthalidone in Dahl salt-sensitive rats on a high-fat, high-salt diet. Clin. Exp. Pharmacol. Physiol. 2014 Aug;41(8):579-88
Jin C et al
2014/01/01
PubMed
10 Wada Y et al. Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models. Exp. Biol. Med. (Maywood) 2016 10;241(16):1865-76
Wada Y et al
2016/01/01
PubMed
11 Zimmerman MA et al. Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males. Am. J. Physiol. Renal Physiol. 2014 May;306(10):F1136-42
Zimmerman MA et al
2014/01/01
PubMed
12 Hye Khan MA et al. Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat. Cardiovasc Drugs Ther 2014 Aug;28(4):313-22
Hye Khan MA et al
2014/01/01
PubMed
13 Khan AH et al. Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. Front Pharmacol 2014;5:216
Khan AH et al
2014/01/01
PubMed
14 Hye Khan MA et al. Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats. Am. J. Hypertens. 2014 Aug;27(8):1087-95
Hye Khan MA et al
2014/01/01
PubMed
15 Brinson KN et al. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013 Oct;305(7):R701-10
Brinson KN et al
2013/01/01
PubMed
16 Maile LA et al. Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats. J Diabetes Res 2014;2014:421827
Maile LA et al
2014/01/01
PubMed
17 Elsherbiny NM et al. Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib. J. Physiol. Biochem. 2015 Dec;71(4):635-48
Elsherbiny NM et al
2015/01/01
PubMed
18 Nagasawa T et al. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib. Clin. Exp. Pharmacol. Physiol. 2012 May;39(5):454-61
Nagasawa T et al
2012/01/01
PubMed
19 Katary MM et al. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels. Prostaglandins Other Lipid Mediat. 2017 09;132:3-11
Katary MM et al
2017/01/01
PubMed
20 Hye Khan MA et al. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat. 2016 09;125:40-7
Hye Khan MA et al
2016/01/01
PubMed
21 Tan CY et al. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy. Nephron 2015;129(2):109-27
Tan CY et al
2015/01/01
PubMed
22 Kandasamy Y et al. Nephrin - a biomarker of early glomerular injury. Biomark Res 2014;2:21
Kandasamy Y et al
2014/01/01
PubMed
23 Elmarakby AA et al. Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 2012 Apr;302(7):F791-800
Elmarakby AA et al
2012/01/01
PubMed
24 Imig JD et al. Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Exp. Biol. Med. (Maywood) 2012 Dec;237(12):1402-12
Imig JD et al
2012/01/01
PubMed
  • No.: 1
  • 文献情報:
    Turbeville HR et al. Superimposed Preeclampsia Exacerbates Postpartum Renal Injury Despite Lack of Long-Term Blood Pressure Difference in the Dahl Salt-Sensitive Rat. Hypertension 2019 03;73(3):650-658
    Turbeville HR et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wang X et al. Spontaneous one-kidney rats are more susceptible to develop hypertension by DOCA-NaCl and subsequent kidney injury compared with uninephrectomized rats. Am. J. Physiol. Renal Physiol. 2016 05;310(10):F1054-64
    Wang X et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Saleh MA et al. Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Hypertension 2010 Nov;56(5):942-9
    Saleh MA et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Brouwers O et al. Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. Diabetologia 2014 Jan;57(1):224-35
    Brouwers O et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Jin C et al. Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome. J. Pharmacol. Exp. Ther. 2014 Nov;351(2):467-73
    Jin C et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kojima N et al. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats. J. Pharmacol. Exp. Ther. 2013 Jun;345(3):464-72
    Kojima N et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chen YM et al. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling. Mol. Med. 2015 Apr;21:276-84
    Chen YM et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Bernardi S et al. Aldosterone effects on glomerular structure and function. J Renin Angiotensin Aldosterone Syst 2015 Dec;16(4):730-8
    Bernardi S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Jin C et al. Antihypertensive and anti-inflammatory actions of combined azilsartan and chlorthalidone in Dahl salt-sensitive rats on a high-fat, high-salt diet. Clin. Exp. Pharmacol. Physiol. 2014 Aug;41(8):579-88
    Jin C et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Wada Y et al. Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models. Exp. Biol. Med. (Maywood) 2016 10;241(16):1865-76
    Wada Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Zimmerman MA et al. Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males. Am. J. Physiol. Renal Physiol. 2014 May;306(10):F1136-42
    Zimmerman MA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Hye Khan MA et al. Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat. Cardiovasc Drugs Ther 2014 Aug;28(4):313-22
    Hye Khan MA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Khan AH et al. Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. Front Pharmacol 2014;5:216
    Khan AH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hye Khan MA et al. Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats. Am. J. Hypertens. 2014 Aug;27(8):1087-95
    Hye Khan MA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Brinson KN et al. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013 Oct;305(7):R701-10
    Brinson KN et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Maile LA et al. Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats. J Diabetes Res 2014;2014:421827
    Maile LA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Elsherbiny NM et al. Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib. J. Physiol. Biochem. 2015 Dec;71(4):635-48
    Elsherbiny NM et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Nagasawa T et al. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib. Clin. Exp. Pharmacol. Physiol. 2012 May;39(5):454-61
    Nagasawa T et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Katary MM et al. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels. Prostaglandins Other Lipid Mediat. 2017 09;132:3-11
    Katary MM et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Hye Khan MA et al. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat. 2016 09;125:40-7
    Hye Khan MA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Tan CY et al. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy. Nephron 2015;129(2):109-27
    Tan CY et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Kandasamy Y et al. Nephrin - a biomarker of early glomerular injury. Biomark Res 2014;2:21
    Kandasamy Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Elmarakby AA et al. Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 2012 Apr;302(7):F791-800
    Elmarakby AA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Imig JD et al. Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Exp. Biol. Med. (Maywood) 2012 Dec;237(12):1402-12
    Imig JD et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed